You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant peripheral nerve sheath tumor (MPNST)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Development to Predict Malignant Conversion in Neurofibromatosis

Recruiting
  • Neurofibromatosis 1
  • +2 more
  • Whole Body Magnetic Resonance Imaging
  • Baltimore, Maryland
    Johns Hopkins University
Dec 22, 2022

Malignant Peripheral Nerve Sheath Tumor Development in

Active, not recruiting
  • Neurofibromatosis 1
  • Peripheral Nerve Neoplasms, Malignant
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Malignant Peripheral Nerve Sheath Tumors (MPNST) Trial in United States (ASTX727)

    Recruiting
    • Malignant Peripheral Nerve Sheath Tumors (MPNST)
    • Basking Ridge, New Jersey
    • +6 more
    Aug 25, 2022

    Peripheral Nerve Sheath Tumor Trial in Gainesville (Tazemetostat)

    Recruiting
    • Peripheral Nerve Sheath Tumor
    • Gainesville, Florida
      University of Florida
    Jan 4, 2023

    Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

    Not yet recruiting
    • Synovial Sarcoma
    • +3 more
    • Afamitresgene autoleucel
    • Palo Alto, California
    • +3 more
    Dec 6, 2022

    Malignant Peripheral Nerve Sheath Tumour (MPNST) Trial in Oslo (Pembrolizumab)

    Terminated
    • Malignant Peripheral Nerve Sheath Tumour (MPNST)
    • Oslo, Norway
      Oslo university Hospital
    Jun 21, 2021

    Soft Tissue Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Leiomyosarcoma Trial in Toronto (Selinexor)

    Recruiting
    • Soft Tissue Sarcoma
    • +3 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Apr 7, 2022

    Wilms Tumor, Rhabdoid Tumor, Malignant Peripheral Nerve Sheath Tumors Trial in United States (Selinexor)

    Recruiting
    • Wilms Tumor
    • +6 more
    • Los Angeles, California
    • +10 more
    Aug 2, 2023

    Pancreatic Cancer, Osteosarcoma, MPNST (Malignant Peripheral Nerve Sheath Tumor) Trial in Santa Monica (DeltaRex-G)

    Available
    • Pancreatic Cancer
    • +6 more
    • Santa Monica, California
      Sarcoma Oncology Research Center, LLC
    Jan 20, 2022

    Neurofibromatosis, MPNST Trial run by the National Cancer Institute (NCI) (MRI, FDG-PET/CT scans, [18F]-FLT-PET/CT scans)

    Completed
    • Neurofibromatosis
    • MPNST
    • MRI, FDG-PET/CT scans
    • [18F]-FLT-PET/CT scans
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Aug 24, 2022

    Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, NF1 Mutation Positive Malignant Peripheral Nerve Sheath Tumor

    Active, not recruiting
    • Advanced Malignant Solid Neoplasm
    • +3 more
    • Pharmacodynamic Study
    • Telaglenastat Hydrochloride
    • Birmingham, Alabama
    • +30 more
    Sep 1, 2022

    Metastatic Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis Type 1, Recurrent Malignant Peripheral Nerve Sheath Tumor

    Recruiting
    • Metastatic Malignant Peripheral Nerve Sheath Tumor
    • +2 more
    • Computed Tomography
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Jul 6, 2022

    Pleuropulmonary Blastoma, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Neuroblastoma Trial in United States

    Completed
    Has Results
    • Pleuropulmonary Blastoma
    • +5 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Birmingham, Alabama
    • +68 more
    Jan 4, 2022

    Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

    Active, not recruiting
    • Malignant Peripheral Nerve Sheath Tumors
    • Neurofibromatosis 1
    • Washington, District of Columbia
    • +4 more
    Apr 1, 2022

    Sarcoma, Malignant Peripheral Nerve Sheath Tumors Trial in United States (PLX3397, Sirolimus)

    Recruiting
    • Sarcoma
    • Malignant Peripheral Nerve Sheath Tumors
    • Iowa City, Iowa
    • +4 more
    Aug 26, 2021

    Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin

    Active, not recruiting
    • Advanced Soft Tissue Sarcoma
    • +26 more
    • Doxorubicin Hydrochloride
    • +3 more
    • Portland, Oregon
      OHSU Knight Cancer Institute
    Jan 6, 2023

    Epithelioid Sarcoma (Ex-US Only), Spindle Cell Sarcoma, Sinonasal Carcinoma Trial (Tazemetostat)

    Temporarily not available
    • Epithelioid Sarcoma (Ex-US Only)
    • +19 more
    • (no location specified)
    Oct 17, 2022

    Sarcoma,Soft Tissue Trial in Spain (Selinexor 20 MG, Gemcitabine)

    Recruiting
    • Sarcoma,Soft Tissue
    • Tenerife, Canarias, Spain
    • +10 more
    Oct 27, 2023

    Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors Trial in Shanghai (AL2846 capsules)

    Recruiting
    • Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
    • AL2846 capsules
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital, School of Medicine, Shanghai J
    Sep 24, 2021

    Mesothelioma, Non Small Cell Lung Cancer, Malignant Peripheral Nerve Sheath Tumors Trial in United States (MRTX1719)

    Recruiting
    • Mesothelioma
    • +5 more
    • Denver, Colorado
    • +5 more
    Aug 8, 2022

    Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma Trial in Memphis (Fludarabine, Cyclophosphamide, MESNA)

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 30, 2022

    Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small

    Recruiting
    • Desmoplastic Small Round Cell Tumor
    • +11 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +8 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 26, 2022

    MPNST, NF1, Sarcoma Trial in United States (Selumetinib)

    Not yet recruiting
    • MPNST
    • +2 more
    • Birmingham, Alabama
    • +13 more
    Jun 29, 2022

    Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second

    Recruiting
    • Pediatric Solid Tumor
    • +15 more
    • second generation 4-1BBζ EGFR806-EGFRt
    • second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    • Seattle, Washington
      Seattle Children's Hospital
    May 2, 2022

    Type I Neurofibromatosis Trial in Shanghai (TQ-B3234 capsule)

    Not yet recruiting
    • Type I Neurofibromatosis
    • TQ-B3234 capsule
    • Shanghai, Shanghai, China
      Shanghai Ninth People's Hospital ，Shanghai JiaoTong University S
    Oct 22, 2021